… dry eye drug MIEBO, which generated $112 million in fourth-quarter sales and helped push dry eye portfolio revenue to $1.1 billion for 2025.
Source: google.com
… dry eye drug MIEBO, which generated $112 million in fourth-quarter sales and helped push dry eye portfolio revenue to $1.1 billion for 2025.
Source: google.com